{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:57:27Z","timestamp":1792421847733,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.drugalcdep.2020.108193","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T21:38:34Z","timestamp":1596231514000},"page":"108193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders"],"prefix":"10.1016","volume":"216","author":[{"given":"Brian","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Paynter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karli","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Kansagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108193_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: an emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Subst. Use Misuse"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108193_bib0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archpsyc.1992.01820110052008","article-title":"Desipramine treatment of cocaine dependence in methadone-maintained patients","volume":"49","author":"Arndt","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0015","series-title":"Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update","author":"Berkman","year":"2013"},{"issue":"1-2","key":"10.1016\/j.drugalcdep.2020.108193_bib0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.drugalcdep.2012.05.019","article-title":"Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial","volume":"126","author":"Carroll","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00952990903108215","article-title":"Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: a systematic review and meta-analysis of controlled clinical trials","volume":"35","author":"Castells","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0030","article-title":"Psychostimulant drugs for cocaine dependence","volume":"9","author":"Castells","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0035","series-title":"Annual Surveillance Report of Drug-related Risks and Outcomes \u2014 United States Surveillance Special Report","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0040","series-title":"Pharmacotherapy for Stimulant Use Disorders: A Systematic Review of the Evidence. VA ESP Project #05-225","author":"Chan","year":"2018"},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108193_bib0045","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/add.14755","article-title":"Pharmacotherapy for methamphetamine\/amphetamine use disorder-a systematic review and meta-analysis","volume":"114","author":"Chan","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0050","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use Disorder-a systematic review and meta-analysis","author":"Chan","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","article-title":"Effects of Mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial","volume":"77","author":"Coffin","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108193_bib0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JCP.0b013e31827bfff4","article-title":"A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription","volume":"33","author":"Dursteler-MacFarland","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108193_bib0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0006-3223(99)00310-8","article-title":"Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial","volume":"47","author":"George","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108193_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonzalez","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108193_bib0085","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study","volume":"98","author":"Gonzalez","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004714-199506000-00004","article-title":"Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials","volume":"15","author":"Grabowski","year":"1995","journal-title":"Journal of clinical psychopharmacology"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0095","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108193_bib0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0376-8716(95)01154-9","article-title":"Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients","volume":"39","author":"Handelsman","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108193_bib0115","first-page":"56","article-title":"Bromocriptine for cocaine dependence: A controlled clinical trial","volume":"6","author":"Handelsman","year":"1997","journal-title":"Am J Addict"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0120","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2019-05-17","author":"Higgins","year":"2011"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108193_bib0125","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"7414","key":"10.1016\/j.drugalcdep.2020.108193_bib0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0135","article-title":"Antipsychotic medications for cocaine dependence","volume":"3","author":"Indave","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108193_bib0140","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/10826089209068770","article-title":"Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine","volume":"27","author":"Kolar","year":"1992","journal-title":"Int. J. Addict."},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108193_bib0145","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archpsyc.1992.01820110058009","article-title":"Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine","volume":"49","author":"Kosten","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(03)00032-2","article-title":"Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients","volume":"70","author":"Kosten","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108193_bib0160","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.13375","article-title":"Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study","volume":"111","author":"Ling","year":"2016","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108193_bib0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/00952999509002711","article-title":"Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients","volume":"21","author":"Margolin","year":"1995","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108193_bib0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","article-title":"A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients","volume":"40","author":"Margolin","year":"1995","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/08897079709511358","article-title":"High- and low-dose mazindol for cocaine dependence in methadone- maintained patients: a preliminary evaluation","volume":"18","author":"Margolin","year":"1997","journal-title":"Substance Abuse: Substance Abuse"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108193_bib0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1300\/J069v22n02_04","article-title":"A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients","volume":"22","author":"Margolin","year":"2003","journal-title":"J. Addict. Dis."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0185","article-title":"Dopamine agonists for the treatment of cocaine dependence","author":"Minozzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108193_bib0190","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006754.pub3","article-title":"Anticonvulsants for cocaine dependence","author":"Minozzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108193_bib0195","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108193_bib0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FBP.0000000000000268","article-title":"Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment","volume":"28","author":"Moran","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0205","series-title":"June 2. Addiction Medications","author":"NIDA","year":"2020"},{"issue":"Suppl","key":"10.1016\/j.drugalcdep.2020.108193_bib0210","first-page":"17","article-title":"Pharmacological and behavioral treatments of cocaine dependence: controlled studies","volume":"49","author":"O\u2019Brien","year":"1988","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108193_bib0215","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.56.9.812","article-title":"Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone","volume":"56","author":"Oliveto","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2020.108193_bib0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2010.07.022","article-title":"Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients","volume":"113","author":"Oliveto","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108193_bib0225","article-title":"Antidepressants for cocaine dependence and problematic cocaine use","author":"Pani","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108193_bib0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108193_bib0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1521-0391.2010.00066.x","article-title":"The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study","volume":"19","author":"Poling","year":"2010","journal-title":"Am. J. Addict."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108193_bib0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J465v26n02_02","article-title":"A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program","volume":"26","author":"Reid","year":"2005","journal-title":"Subst. Abus."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0250","series-title":"Version 5.3. Copenhagen: The Nordic Cochrane Centre","author":"Review Manager (RevMan) [Computer program]","year":"2014"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108193_bib0255","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.1997.01830200041006","article-title":"Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse","volume":"54","author":"Schottenfeld","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108193_bib0260","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.162.2.340","article-title":"Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence","volume":"162","author":"Schottenfeld","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2013.12.007","article-title":"Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment","volume":"136","author":"Schottenfeld","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants \u2014 United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1037\/1064-1297.15.5.453","article-title":"Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study","volume":"15","author":"Sofuoglu","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0280","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsat.2016.11.005","article-title":"Carvedilol does not reduce cocaine use in methadone-maintained cocaine users","volume":"73","author":"Sofuoglu","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0285","series-title":"Treatment Improvement Protocol TIP 63. HHS Publication No. (SMA) 18-5063FULLDOC. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration","article-title":"Medications for opioid use disorder - for healthcare and addiction professionals, policymakers, patients, and families","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2018"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108193_bib0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","article-title":"Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial","volume":"169","author":"Tiihonen","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108193_bib0295","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2014.03.033","article-title":"Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial","volume":"140","author":"Umbricht","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108193_bib0300","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3758","article-title":"Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108193_bib0305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsat.2010.11.010","article-title":"A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients","volume":"40","author":"Winstanley","year":"2011","journal-title":"J Subst Abuse Treat"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:07:08Z","timestamp":1759828028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620303586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":61,"alternative-id":["S0376871620303586"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108193","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108193"}}